When:
Saturday, September 14, 2024
8 a.m. to 3 p.m.
Registration & Breakfast 7 to 8 a.m.
TriHealth is notifying individuals whose information was involved in a recent third-party data security incident. Click here for more information. Click here for additional information on the recent Datavant Breach.
Nearly 100 medical professionals from across the region registered for this 2024 conference and attendees walked away, not only with continuing medical education credits, but a stronger understanding of the many aspects of cardiac amyloidosis. Thanks to all our speakers and sponsors.
Hope to see you next time!
The TriHealth Heart & Vascular Institute presents “The Present State and Future Direction” of Cardiac Amyloidosis. Join TriHealth’s multidisciplinary team of experts for engaging presentations and interactive conversations on the varied aspects of amyloidosis care.
Learn the signs, symptoms, treatments, healthcare disparities and benefits of early referral for cardiac amyloidosis from TriHealth experts and renowned cardiac amyloid specialists, Trejeeve Martyn, MD, MSc, and Andres Carmona Rubio, MD, from Cleveland Clinic.
Saturday, September 14, 2024
8 a.m. to 3 p.m.
Registration & Breakfast 7 to 8 a.m.
Manor House Event & Conference Center
7440 S. Mason-Montgomery Road
Mason, Ohio 45040
Trejeeve Martyn, MD, MSc, of Cleveland Clinic, discussing the development of systems of care to address racial disparities and late diagnosis in Transthyretin Amyloid Cardiomyopathy.
Andres Carmona Rubio, MD, of Cleveland Clinic, presenting current research and future direction of clinical trials.
TriHealth Heart & Vascular Institute specialists will host various sessions on topics surrounding Amyloidosis, including pathophysiology, imaging, management, advanced heart failure, multidisciplinary care coordination.
Collaborative TriHealth specialists will add perspectives on laboratory analysis, gastrointestinal manifestations, financial implications of therapies and palliative care.
Contact hours are available.